UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Investigating the development and evolution of drug resistance in the HIV-1 pol gene

Martin, AS; (2013) Investigating the development and evolution of drug resistance in the HIV-1 pol gene. Doctoral thesis (PhD), UCL (University College London). Green open access

[thumbnail of AS_Martin_thesis.pdf]
Preview
Text
AS_Martin_thesis.pdf

Download (4MB) | Preview

Abstract

The prognosis of those infected with HIV-1 has improved significantly since the introduction of highly active antiretroviral therapy (HAART). This has led to complete suppression of HIV-1 replication and reduction of viraemia to undetectable levels. Initially HAART comprised of three classes of drugs, namely nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), which target two important viral enzymes. Until recently, patients developing highly drug-resistant HIV-1 have had limited therapy options. This has changed in the last few years with the development and approval for use of second-generation NNRTIs and PIs, and three new classes of drugs including integrase strand transfer inhibitors (INSTIs). This means that patients undergoing INSTI-containing salvage therapy are taking drugs targeting all three HIV-1 pol genes; protease (PR), RT and IN. However, little data is available on the evolution, interaction and linkage of drug resistance mutations throughout the pol gene. In this study, we developed a single genome sequencing assay of the full-length HIV-1 pol gene and used it to investigate the development and linkage of drug resistance mutations in sequential samples from two patients failing INSTI-containing salvage therapy. Different phylogenetic methods were used to explore the evolution and dynamics of drug resistance mutations in the full-length HIV-1 pol gene. Furthermore, we examined the effect of co-evolved PR and RT on the susceptibility of patient-derived viruses to INSTIs and viral replicative fitness. Our data indicate that the development of drug resistance mutations in IN is complex and is a fine balance between attaining high levels of drug resistance and decent replicative fitness. This is to a degree influenced by mutations in other regions of the HIV-1 pol gene. Taken together, the data suggests that larger regions of patient-derived HIV-1 genome should be examined in order to get a good understanding of HIV-1 drug susceptibility.

Type: Thesis (Doctoral)
Qualification: PhD
Title: Investigating the development and evolution of drug resistance in the HIV-1 pol gene
Open access status: An open access version is available from UCL Discovery
Language: English
Keywords: HIV-1 resistance, pol gene evolution, drug resistance mutation linkage, single genome sequencing, single cycle replication, Raltegravir and elvitegravir susceptibility, Reverse transcriptase C terminal resistance
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/1413952
Downloads since deposit
309Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item